Well, if that one six cell had something property about it, that was going to get you.

But has that been shown to be the case?

Well, if it was, you know, as I say, if you had a way of, if you, when you kill, when

you try to kill cancer cells, you kill a lot of healthy cells too.

It's not a very effective treatment, but the argument is you're going to, you got nothing

else to do, you're going to try to kill a cancer, hopefully it's more susceptible to

the chemical than the healthy cells.

Now, in this case, they have the same argument except for the fact that they say you're going

to keep on using this drug knowing that it's killing your healthy cells until you die.

You're not going to take it for two weeks and then hope that you've killed all the HIV

and now you will be alive.

It's not like that.

They said, no, we're going to do the same thing that we do to cancer, but we're just going

to keep on doing it until you die.

And hopefully it's going to prolong your life.

So, if it doesn't prolong your life, what they look for is surrogate markers, and you

heard that term, battered about, surrogate markers mean, well, it doesn't seem to do anything

for the disease, but it does, every now and then, do something for the level of CD4

cells that we measure, or it does something for this or that.

Not that anybody really knows whether you want more or less CD4 cells in any particular

time in your life.

A lot of diseases call CD4 to go up, a lot of diseases have caused me to go down.

...